By Sandy Lunoe, Guest Author
Will vaccines produced using human cancer cells make vaccines more likely to cause cancer?
Do the amounts of residual cancer DNA present in the vaccines vary between batches?
What genetic mutations could occur should the residual cancer DNA enter a human cell and begin reproducing?
Will manufacturers be obliged to conduct adequate safety studies before these vaccines are licensed?
The truth is no one knows.
Never before have cells that are derived directly from human cancer tumors been considered for use in vaccine production. Incredibly, this method has been approved despite the fact that it cannot be guaranteed that the vaccines will not induce cancer tumors in recipients.
Based on the approval by FDA (Food and Drug Administration) millions of vaccines which may induce cancer tumors will be produced. Where are the protests?
From a salvaged transcript (1) of the several hour long meeting in September 2012 between FDA and vaccine manufacturers some of the statements which jumped out of the page are quoted in this article…
